Background: The class A carbapenemase KPC has disseminated rapidly worldwide, challenging the treatment of Gram-negative infections. This report describes the first KPC-producing Klebsiella pneumoniae isolates identified in Norway (n5 6) and the second isolate from Sweden.
Introduction
The Klebsiella pneumoniae carbapenemase (KPC) is a class A b-lactamase that confers resistance to virtually all b-lactam antibiotics including carbapenems. 1, 2 It was first reported in the USA in a K. pneumoniae isolate from 1996. 3 Since then, KPC-producing K. pneumoniae have increased in prevalence and been responsible for outbreaks in parts of the USA and Israel. 4, 5 Reports are now appearing showing that KPC enzymes have disseminated worldwide with KPC-producing isolates identified in France, Greece, Colombia, Argentina, China and the UK. 1,2,6 -9 In Scandinavia, the first isolate producing KPC-2 was identified in 2007 in Sweden from a patient previously hospitalized in an intensive care unit in Greece. 10 Initially discovered in K. pneumoniae, KPC enzymes have now been detected in several other members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
1,2 The rapid dissemination and spread among different bacterial species of KPC enzymes are likely due to the localization of bla KPC genes on transferable broad host range plasmids and their association with transposons and IS elements. 11 Clonal dissemination of KPC-producing K. pneumoniae isolates is often observed within countries but also between countries, indicating that there are major international clones circulating.
This study reports the first identification of KPC-producing K. pneumoniae in Norway along with epidemiological and genetic characterization of the Norwegian isolates and the second Swedish isolate identified.
Materials and methods

Bacterial isolates
The clinical isolates were referred to the Reference Centre for Detection of Antimicrobial Resistance in Norway and Karolinska University Hospital in Sweden based on non-susceptibility to carbapenems by disc diffusion and for the investigation of the resistance mechanisms (Table 1) . Bacterial identification was performed using the Vitek2 ID-GNB system (bioMérieux, Marcy l'É toile, France).
Antibiotic susceptibility testing
The antibiotic susceptibility profile of the isolates was determined using Etest according to the manufacturer's instructions (AB BIODISK, Solna, Sweden) and interpreted according to clinical breakpoints from the European Committee for Antimicrobial Susceptibility Testing (EUCAST).
PCR amplification and DNA sequencing
Isolates were screened for the presence of bla KPC by PCR, and the genetic structure surrounding bla KPC genes was investigated using combinations of primers, as described by Naas et al. 11 Consensus PCR for bla TEM , bla SHV , bla CTX-M and a multiplex PCR for bla AmpC genes were performed, as described previously. 12, 13 Sequencing of positive PCR products and partial sequencing of the genetic structure were performed using BigDye 3.1 technology (Applied Biosystems, Foster City, CA, USA). Sequence analysis and alignments were performed using SeqManII software (DNAStar, Madison, WI, USA) and compared with sequences deposited in the GenBank database (www.ncbi.nlm.nih.gov).
PFGE
Isolates were typed by PFGE of XbaI-digested genomic DNA using the Chef-DR w III System (Bio-Rad, Marnes-La-Coquette, France). Electrophoresis was run at 128C with a pulse time of 1-20 s at 6 V/cm on a 1208 angle in 0.5Â Tris/borate/EDTA (TBE) buffer for 21 h. DNA relatedness was computationally analysed in GelCompar II (Applied Maths, Sint-Martens-Latem, Belgium) using the band-based dice similarity coefficient and the unweighted pairs geometric-matched analysis dendrogram with a position tolerance of 1% for optimization and band comparison.
Multilocus sequence typing (MLST)
MLST was performed according to the protocol described on the K. pneumoniae MLST web site (http://www.pasteur.fr/recherche/ genopole/PF8/mlst/Kpneumoniae.html).
S1 nuclease digestion and Southern blot hybridization S1 nuclease-digested (Promega, Southampton, UK) genomic DNA from all isolates was examined by PFGE, run in a Chef-DR w III System (Bio-Rad), at 158C, with a pulse time of 5-25 s for 6 h (block 1) and 30 -45 s for 18 h (block 2), at 6 V/cm on a 1208 angle in 0.5Â TBE buffer.
14 Each band was considered a unit length linear plasmid. Plasmids were blotted onto positively charged nylon membranes (Roche Applied Sciences, Penzberg, Germany) using the VacuGene TM XL Vacuum Blotting System (GE Healthcare Life Sciences, Buckinghamshire, UK) for transfer and hybridized with bla KPC gene probes generated by the PCR DIG Probe Synthesis Kit and detected using the DIG Luminescent Detection Kit (Roche Applied Sciences).
Results and discussion
The isolates were positive for bla KPC by PCR and showed a multidrug-resistant phenotype (Table 1 ). All isolates expressed high-level resistance to penicillins, cephalosporins and aztreonam, but showed varying levels of resistance to carbapenems. All isolates were resistant to ertapenem. Two isolates were resistant to imipenem, whereas three and two isolates were susceptible (MIC 2 mg/L) or intermediate susceptible (MIC 4 mg/L), respectively. Four isolates expressed resistance to meropenem, and three isolates were intermediate susceptible (MIC 4-8 mg/L). Moreover, the isolates were resistant or intermediate susceptible to amikacin, tobramycin and ciprofloxacin, but were all susceptible to gentamicin (MICs 1-2 mg/L). Further, two isolates were also resistant to colistin (MIC 8-16 mg/L), and six isolates were resistant or intermediate susceptible to tigecycline (MICs 2-4 mg/L). The resistance profile with susceptibility to gentamicin is similar to K. pneumoniae KPC-producing isolates from Israel and the UK. 7, 15 All isolates were PCR-negative for bla AmpC and bla CTX-M genes. The presence of both bla SHV-11 and bla SHV-12 was found in isolates from Norway, while the Swedish isolate carried only bla SHV-11 . All isolates carried bla TEM-1 .
Previous studies regarding metallo-b-lactamase-producing P. aeruginosa and the identification of the first KPC-producing K. pneumoniae in Sweden have shown that the introduction of new mobile resistance mechanisms in Scandinavia has been associated with import. 10, 16, 17 In this study, five of the isolates were likely import cases. Three isolates (K47-25, K52-10 and AO-8053) were derived from patients upon admission to the Norwegian or Swedish hospital after direct transfer from hospitals in Greece or Israel, respectively (Table 1) . Coincidentally, the patients carrying K47-25 and K52-10 had been treated at the same hospital in Greece. The patient carrying isolates K52-36 and K52-37 had been admitted to a hospital in Greece 3 months prior to the identification of the isolates. The other isolates (K48-58 and K52-43) were derived from patients with no history of hospitalization outside Norway. PFGE of XbaIdigested genomic DNA revealed that all isolates were clonally related (Dice coefficient !87%), but with minor differences (Figure 1a) . The two isolates (K52-36 and K52-37) from the patient at Asker and Baerum Hospital (Eastern Norway) showed a three band difference, indicating co-infection or recent in vivo diversification. Isolates K47-25 and K52-10 likely imported from Greece were indistinguishable from isolate K52-43, which was not associated with import. K52-43 (Førde Central Hospital, Western Norway) is a possible local nosocomial transmission case as the patient had been admitted to the Haukeland University Hospital (Western Norway) at the same time as the patient carrying K52-10. Although the patients were not simultaneously admitted to the same unit, contact with the same healthcare personnel cannot be ruled out. Isolate K52-37 was indistinguishable from K48-58 from Sørlandet Hospital, Kristiansand (Southern Norway). However, there were no discernable epidemiological connections between the cases or with the other cases. The Swedish isolate imported from Israel was most closely related to two of the isolates imported from Greece (K47-25 and K52-10). MLST confirmed the clonal relationship between the isolates. MLST typing of K47-25, K48-58 and AO-8053 showed that the isolates displayed ST258, a recently described single locus variant of ST11. The ST11 variant has previously been described in Europe among ciprofloxacin-resistant CTX-M-15-producing epidemic clones in Hungary. 18 However, bla CTX-M PCR was negative for all the KPC isolates.
Sequencing analysis showed that all Norwegian isolates harboured bla KPC-2 , while the Swedish isolate carried bla KPC-3 . KPC-3-producing K. pneumoniae have previously been identified as the dominant variant in Israel, 5, 15 consistent with the likely import from Israel. Partial sequencing revealed that bla KPC in all isolates was part of isoform a of Tn4401 previously found in isolates from Greece and France (US origin). 11 S1 nuclease digestion followed by PFGE showed that all isolates harboured multiple plasmids (Figure 1b) . Southern blot and hybridization with a bla KPC probe showed that bla KPC was plasmid located in all isolates (Figure 1c ). bla KPC-3 was located on a plasmid of $120 kb, while bla KPC-2 was located on a plasmid of $100 kb. Isolate K47-25 also harboured bla KPC-2 on an additional plasmid of $160 kb. Tn4401 is a Tn3-like element that supports replicative transposition and has previously been described in different genetic environments in plasmids flanked by target site duplications. 11 The observation of bla KPC on two plasmids in one isolate further supports the hypothesis that Tn4401 contributes to the mobilization and dissemination of bla KPC .
In conclusion, KPC-producing K. pneumoniae have emerged in Norway and Sweden through four separate incident of import with a clonally related strain from Greece and Israel. Dissemination of this clone in Norway has occurred with one case of local transmission. Two additional KPC-producing K. pneumoniae isolates have recently been identified in Norway, of which one is another isolate imported from Greece while the other isolate probably represents further dissemination in that health region (data not shown). The dissemination of this clone illustrates the epidemic potential. The clonality between the isolates and the close phylogenetic relation to CTX-M-15-producing K. pneumoniae from Hungary 18 indicates the dissemination of international biologically fit clones of K. pneumoniae with a high potential to acquire resistance mechanisms. The rapid dissemination of KPC enzymes in Enterobacteriaceae and P. aeruginosa worldwide and the consequences for treatment and infection control measures warrant a high degree of awareness and monitoring of these enzymes. 
